Application 207986
- Type
- NDA
- Sponsor
- OTONOMY INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OTIPRIO | CIPROFLOXACIN | INJECTABLE, SUSPENSION;OTIC | 6% (60MG/ML) | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N207986-001 | OTIPRIO | CIPROFLOXACIN | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N207986-001 | 11369566 | 2029-04-21 | Drug product | 2022-07-14 | |
| N207986-001 | 9205048 | 2029-04-21 | U-1793 | 2016-01-11 | |
| N207986-001 | 9603796 | 2029-04-21 | U-2252 | Drug substance, Drug product | 2018-03-26 |
| N207986-001 | 9233068 | 2029-12-11 | Drug product | 2016-02-05 | |
| N207986-001 | 8318817 | 2030-04-27 | U-1792 | 2016-01-11 | |
| N207986-001 | 9220796 | 2035-07-01 | Drug product | 2016-01-11 | |
| N207986-001 | 11040004 | 2037-11-12 | U-2252 | 2021-07-21 | |
| N207986-001 | 11246863 | 2038-11-27 | Drug product | 2022-03-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD | 2015-12-10 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N207986-001 | OTIPRIO | 6% (60MG/ML) | INJECTABLE, SUSPENSION / OTIC | RLD, RS | 2015-12-10 | f41ea6bd6efb… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N207986-001 | 11369566 | 2029-04-21 | Drug product | 2022-07-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207986-001 | 9205048 | 2029-04-21 | U-1793 | 2016-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207986-001 | 9603796 | 2029-04-21 | U-2252 | Drug substance, Drug product | 2018-03-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N207986-001 | 9233068 | 2029-12-11 | Drug product | 2016-02-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207986-001 | 8318817 | 2030-04-27 | U-1792 | 2016-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207986-001 | 9220796 | 2035-07-01 | Drug product | 2016-01-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207986-001 | 11040004 | 2037-11-12 | U-2252 | 2021-07-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N207986-001 | 11246863 | 2038-11-27 | Drug product | 2022-03-11 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N207986-001 | 11369566 | 2029-04-21 | Drug product | 2022-07-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207986-001 | 9205048 | 2029-04-21 | U-1793 | 2016-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207986-001 | 9603796 | 2029-04-21 | U-2252 | Drug substance, Drug product | 2018-03-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N207986-001 | 9233068 | 2029-12-11 | Drug product | 2016-02-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207986-001 | 8318817 | 2030-04-27 | U-1792 | 2016-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207986-001 | 9220796 | 2035-07-01 | Drug product | 2016-01-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207986-001 | 11040004 | 2037-11-12 | U-2252 | 2021-07-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N207986-001 | 11246863 | 2038-11-27 | Drug product | 2022-03-11 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207986-001 | 11369566 | 2029-04-21 | Drug product | 2022-07-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207986-001 | 9205048 | 2029-04-21 | U-1793 | 2016-01-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207986-001 | 9603796 | 2029-04-21 | U-2252 | Drug substance, Drug product | 2018-03-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N207986-001 | 9233068 | 2029-12-11 | Drug product | 2016-02-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207986-001 | 8318817 | 2030-04-27 | U-1792 | 2016-01-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207986-001 | 9220796 | 2035-07-01 | Drug product | 2016-01-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207986-001 | 11040004 | 2037-11-12 | U-2252 | 2021-07-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N207986-001 | 11246863 | 2038-11-27 | Drug product | 2022-03-11 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207986-001 | 11369566 | 2029-04-21 | Drug product | 2022-07-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207986-001 | 9205048 | 2029-04-21 | U-1793 | 2016-01-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207986-001 | 9603796 | 2029-04-21 | U-2252 | Drug substance, Drug product | 2018-03-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207986-001 | 9233068 | 2029-12-11 | Drug product | 2016-02-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207986-001 | 8318817 | 2030-04-27 | U-1792 | 2016-01-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207986-001 | 9220796 | 2035-07-01 | Drug product | 2016-01-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207986-001 | 11040004 | 2037-11-12 | U-2252 | 2021-07-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N207986-001 | 11246863 | 2038-11-27 | Drug product | 2022-03-11 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207986-001 | 11369566 | 2029-04-21 | Drug product | 2022-07-14 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207986-001 | 9205048 | 2029-04-21 | U-1793 | 2016-01-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207986-001 | 9603796 | 2029-04-21 | U-2252 | Drug substance, Drug product | 2018-03-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N207986-001 | 9233068 | 2029-12-11 | Drug product | 2016-02-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207986-001 | 8318817 | 2030-04-27 | U-1792 | 2016-01-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207986-001 | 9220796 | 2035-07-01 | Drug product | 2016-01-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207986-001 | 11040004 | 2037-11-12 | U-2252 | 2021-07-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N207986-001 | 11246863 | 2038-11-27 | Drug product | 2022-03-11 | 6a471c1ec25d… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N207986-001 | I-770 | 2021-03-02 | 74a2ff9319b5… |
| 2021-12-28 21:50 UTC | 2021-12 | N207986-001 | I-770 | 2021-03-02 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N207986-001 | I-770 | 2021-03-02 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N207986-001 | I-770 | 2021-03-02 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N207986-001 | I-770 | 2021-03-02 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N207986-001 | I-770 | 2021-03-02 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N207986-001 | I-770 | 2021-03-02 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N207986-001 | I-770 | 2021-03-02 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N207986-001 | I-770 | 2021-03-02 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ciprofloxacin | CIPROFLOXACIN | Direct_Rx | 36d6c27d-45dc-3081-e063-6394a90a87e9 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | Preferred Pharmaceuticals, Inc. | 85c48ebc-d94a-4254-86df-d2c1aff09b37 | 2026-01-13 | Warnings, Adverse reactions | CIPROFLOXACIN |
| Ciprofloxacin | CIPROFLOXACIN | Northwind Health Company, LLC | f6debb60-d885-230b-e053-6394a90ad73a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| Ciprofloxacin | CIPROFLOXACIN | Northwind Health Company, LLC | f67d727f-b9ca-aec0-e053-2995a90aab69 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| Ciprofloxacin | CIPROFLOXACIN | QPharma Inc | 4d5afeff-3917-43e1-9d12-d70ccab00dcc | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | Chartwell RX, LLC | 905503ef-4277-44ca-aa4a-5a969a041e16 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| Ciprofloxacin | CIPROFLOXACIN | PD-Rx Pharmaceuticals, Inc. | 74e2dd24-5c6e-4dde-a2ab-f2d2e61734d8 | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| Ciprofloxacin in Dextrose | CIPROFLOXACIN | ProPharma Distribution | 42c758be-4d44-018a-e063-6294a90ae041 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| Ciprofloxacin in Dextrose | CIPROFLOXACIN | Hospira, Inc. | cbbbf939-3219-4515-a48e-ca264daa4d07 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| Ciprofloxacin | CIPROFLOXACIN | Method Pharmaceuticals, LLC | acb03e72-ce94-58c5-e053-2a95a90a683a | 2025-10-21 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | QPharma, Inc. | 4149d980-a6cd-c06d-e063-6394a90a47a1 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | Rising Pharma Holdings, Inc. | ef468722-68cd-440b-afd7-2285029db41f | 2025-07-18 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | PD-Rx Pharmaceuticals, Inc. | 2491e6a9-3415-43b9-b31b-67331f52806a | 2025-06-04 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | PD-Rx Pharmaceuticals, Inc. | e81341c6-0e25-4860-adda-2d3cebe88d62 | 2025-06-04 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | PD-Rx Pharmaceuticals, Inc. | 178dc379-e2b8-4b47-9f0c-3fc7fb435c36 | 2025-06-03 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | A-S Medication Solutions | c12b316f-811c-48b6-a320-d314991aa74f | 2025-04-04 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | Bryant Ranch Prepack | 69df48cc-76b6-428e-891a-c25e07d785f8 | 2025-03-28 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | Bryant Ranch Prepack | a5ecc693-b8fd-4a7a-8040-e56f801c9353 | 2025-03-28 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | Advanced Rx of Tennessee, LLC | 30cb2b42-aa4b-8cec-e063-6394a90aa615 | 2025-03-20 | Warnings, Adverse reactions | CIPROFLOXACIN |
| ciprofloxacin | CIPROFLOXACIN | Coupler LLC | 2fff7a38-2c4e-d343-e063-6294a90aca3c | 2025-03-10 | Boxed warning, Warnings, Adverse reactions | CIPROFLOXACIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0268-8200 | OTIPRIO | OTIPRIO | ALK-Abello, Inc. | NDA | Current |
| 0268-8200 | OTIPRIO | OTIPRIO | ALK-Abello, Inc. | NDA | Current |
| 69251-201 | Otiprio | ciprofloxacin | Otonomy, Inc. | NDA | Current |
| 69251-201 | Otiprio | ciprofloxacin | Otonomy, Inc. | NDA | Current |
| 69251-201 | Otiprio | ciprofloxacin | Otonomy, Inc. | NDA | Current |
| 69251-201 | Otiprio | ciprofloxacin | Otonomy, Inc. | NDA | Current |
| 69251-201 | Otiprio | ciprofloxacin | Otonomy, Inc. | NDA | Current |